Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30138% above fair value
$287.47−1.01 (-0.35%)
Close on Nov 17, 2026Market cap $41.44BP/E –Yield –
Natera price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Natera's price to book ratio was 25.2× on Nov 11, 2026, against 26.2× a year earlier. Over the last 5 years it ranged from 5.1× to 32.7×, with a median of 15.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 25.2× | +0.1 |
| 2025 | Dec 31, 2025 | 25.2× | +2.8 |
| 2024 | Dec 31, 2024 | 22.4× | +12.9 |
| 2023 | Dec 29, 2023 | 9.5× | −1.3 |
| 2022 | Dec 30, 2022 | 10.8× | −0.8 |
| 2021 | Dec 31, 2021 | 11.6× | −4.2 |
| 2020 | Dec 31, 2020 | 15.8× | −12.3 |
| 2019 | Dec 31, 2019 | 28.2× | +13.0 |
| 2018 | Dec 31, 2018 | 15.2× | −0.8 |
| 2017 | Dec 29, 2017 | 16.0× | +11.8 |
| 2016 | Dec 30, 2016 | 4.2× | +1.6 |
| 2015 | Dec 31, 2015 | 2.6× | – |
See a number that looks wrong?